A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Elarekibep in Healthy Japanese Subjects

Stopped This decision was based on lung findings from a non-clinical 13-week GLP toxicology study, which are not a concern for the active clinical studies but do not support long-term use and progression to later-stage development.

Conditions

• Healthy Subjects (Indication: Asthma)

Interventions

• DRUG: Elarekibep
• DRUG: Placebo

Sponsor

AstraZeneca

Collaborators

• [object Object]